Join the APOLLOE4 Alzheimer’s Research Study
Find help for Alzheimer's by participaing in the APOLLOE4 study designed to slow the progression of Alzheimer's Disease.
.jpg "HS-CRP TEST (3)")
About the APOLLOE4 Study
Our team of medical professionals is evaluating an investigational drug that is designed to slow the progression of Alzheimer's disease.
The study drug, ALZ-801, is a tablet that is taken twice daily. It has been well-tolerated in earlier studies and a convenient option for Alzheimer's patients and their families.
About Alzheimer's Disease
Alzheimer's disease is a progressive neurologic disorder that causes the brain to shrink (atrophy) and brain cells to die. Alzheimer's disease is the most common cause of dementia — a continuous decline in thinking, behavioral and social skills that affect a person's ability to function independently.
No cure exists, but current medications may temporarily help with symptoms.
Why Is This Study Important?
There is an urgent need for safe and effective treatments that can slow the progression of Alzheimer's Disease. At this time, there are no approved drugs that can halt or arrest the clinical decline typical of the disease.
If you decide to join the APOLLOE4 study, your health and safety will carefully be monitored by specialists, and your participation will help doctors evaluate the study drugs to measure it's effectivity.
Why you should participate:
Access to the study drug for 18 months that may slow your Alzheimer's progression.
Close care and monitoring from an Alzheimer's Disease specialist.
The opportunity to help advance the treatment of Alzheimer's disease.
Reimbursement for study-related time and travel expenses.
Who can participate?
You may be eligible to join if you are:
.png?width=110&height=110&name=Untitled%20design%20(9).png "Untitled design (9)")
Memory Loss due to Alzhemer's Disease
Symptoms
Between 50 to 80 Years
Age
All
Gender
Required
Study Partner
We can help confirm if you have Alzheimer's Disease at no cost. Other study eligibility criteria include being positive for APOE4/4 gene (genetic testing will be provided at no cost.)
Please note that this study may require a study partner. If this has stopped you from participating in the past, please get in touch to discuss your eligibility for this new study.
If you are interested in participating in this Alzheimer’s Disease research study, or think a loved one may be interested, please take the 3min pre-screening questionnaire below.
Find out if you qualify for this clinical study.
Please answer the questions below to see if you may be eligible for the APOLLOE4 Study.
Completing this questionnaire does not obligate you to participate in the study. Your answers will help determine if you may be eligible. If your answers indicate you may be eligible, you will have the opportunity to contact a clinic site near you to learn more about the study.
For more information about the study:
Please visit the APOLLOE4 study page on:
If you have problems accessing the website or have questions regarding the study please contact the research team via email (roxanne.cabading@neurosearch-usa.com) or phone (16262502070 ext 799)
